Robert W Baird
View Older Stories View More Recent Stories
-
Research in Motion (RIMM) volatility elevated; shares near five-year low
-
Baird Downgrades MasterCard (MA) to Neutral
-
Morning Movers 09/13: (FTWR) (LPH) (QRE) Higher; (GOK) (SVM) (ITMN) Lower
-
Baird Upgrades QR Energy (QRE) to Outperform
-
Baird Maintains a 'Neutral' on Biogen (BIIB); Hemophilia Update Moderately Incremental; Still All About BG-12
-
Baird Maintains an 'Outperform' on InterMune (ITMN); Positive on Esbriet Launch Update and Pricing
-
Baird Upgrades Investors Real Estate Trust (IRET) to Outperform
-
Baird Maintains a 'Neutral' on Dendreon (DNDN); Restructuring Plan Helpful But Top-Line Trajectory No More Certain
-
Baird Maintains a 'Neutral' on Acorda Therapeutics (ACOR); Zanaflex Could Soon See Generic Competition, But DCF Impact Is Limited
-
KeyBanc Cuts Price Target on Terreno Realty (TRNO) Following Meeting With Management
-
Baird Says Buy Gilead (GILD) Following Amendments to HCV Trial for GS 9190
-
Baird Maintains an 'Outperform' on Pharmasset (VRUS); Delivering the Goods; Excellent SVR12 for '7977
-
Baird Maintains an 'Outperform' on Celgene (CELG); New Survey Indicates Q211 Abraxane Upside Was No Fluke
-
Notable Analyst Rating Changes 09/02: (EDMC) (ZQK) (UPS) Upgraded; (NLY) (EV) (FDX) Downgraded
-
Baird Maintains a 'Neutral' on Dendreon (DNDN); Lowering Estimates & PT
-
Baird Upgrades Quiksilver (ZQK) to Outperform
-
Mobile Managed Services Provider MobiTV (MBTV) Files $75M IPO
-
Notable Analyst Rating Changes 08/25: (BHP) (FFIV) (AEO) Upgraded; (ECA) (UTHR) (HPQ) Downgraded
-
Baird Upgrades Synchronoss Technologies (SNCR) to Outperform
-
Baird Starts Achillion Pharmaceuticals (ACHN) at Outperform; Pure Play in a HCV Sweet Spot
-
Baird Starts Inhibitex (INHX) at Outperform; Pure Play in a HCV Sweet Spot
-
Notable Analyst Rating Changes 08/24: (ELN) (TSO) (SKS) Upgraded; (BSX) (X) (UTHR) Downgraded
-
Baird Starts Google (GOOG) at Outperform
-
Baird Starts ValueClick, Inc (VCLK) at Neutral
-
Baird Upgrades Arctic Cat (ACAT) to Outperform
-
Baird Upgrades Polaris Industries (PII) to Outperform
-
Notable Analyst Rating Changes 08/19: (RIMM) (DELL) (INTU) Upgraded; (HPQ) (LDK) (SCHW) Downgraded
-
Baird Reiterates an 'Outperform' on Endocyte (ECYT); Remains Top Small-Cap Pick
-
Baird Downgrades Hewlett-Packard (HPQ) to Neutral
-
Baird Downgrades HCP (HCP) to Neutral
-
Baird Upgrades Abercrombie & Fitch (ANF) to Outperform
-
Baird Maintains a 'Neutral' on Regeneron Pharma (REGN); Updating Model for EYLEA Delay; Remain Cautious
-
DeVry (DV) volatility elevated as shares sell off on weak enrollment
-
Baird Downgrades DeVry (DV) to Neutral
-
Baird Upgrades Xcel Energy (XEL) to Outperform
-
Baird Upgrades Aqua America (WTR) to Outperform
-
Baird Upgrades Wisconsin Energy (WEC) to Outperform
-
Baird Upgrades Southwestern Energy (SWN) to Outperform
-
Baird Upgrades Qlik Technologies (QLIK) to Outperform
-
Baird Maintains an 'Outperform' on Vertex (VRTX); Latest HCV Survey Suggests Incivek Launch Should Remain a Positive Story
-
Baird Upgrades Itron (ITRI) to Neutral
-
Baird Upgrades ClearBridge Energy (EMO) to Outperform
-
Baird Upgrades Tortoise North American Energy (TYN) to Outperform
-
Baird Upgrades Woodward (WWD) to Outperform
-
Baird Reiterates an 'Outperform' on Affymax (AFFY); Valuation Remains Inexpensive
-
Baird Upgrades CH Robinson (CHRW), Downgrades JB Hunt (JBHT), CSX (CSX)
-
Baird Upgrades SBUX, YUM to Outperform, Downgrades CAKE, TXRH to Neutral
-
Baird Upgrades UDR, Inc. (UDR) to Outperform
-
Baird Upgrades Home Properties (HME) to Outperform
-
Baird Upgrades Camden Property Trust (CPT) to Outperform
